藥學前沿大講堂第115講-Disposition of Phenolics via Glucuronidation: Progresses and Challenges
Disposition of Phenolics via Glucuronidation: Progresses and Challenges
題 目:Disposition of Phenolics via Glucuronidation: Progresses and Challenges
報告人:Ming Hu, Ph.D, Professor
Department of Pharmacological and Pharmaceutical Sciences at Texas Medical Center,College of Pharmacy, University of Houston
主持人:黃民 院長 太阳集团1088vip
時 間:2012年3月27日(周二)下午3:30
地 點:中山大學東校區太阳集团1088vip 125講學廳
Current Grant and Contract Support (all costs are total cost):
1. NIH 2R01GM070737-0310 National Institute of General Medicine. Disposition of Flavonoids via Metabolic Interplay (competitive renewal). 8/01/09-7/31/13. PI: Ming Hu. The direct cost (all to Hu) is $175,000 ($262,500 total cost) per year for 4 years.
2. NIH 3R01GM070737-04S1 National Institute of General Medicine. Supplement to Disposition of Flavonoids via Metabolic Interplay. 8/01/10-7/31/13. PI: Ming Hu. The direct cost ($48,000 to Hu) is $90,000 ($135,000 total cost) per year for 3 years.
Invited Presentations:
1. Computational Modeling of UGT for Better Prediction of Its Functionality and Structure. Controlled Release Society, China Section, Shanghai, China (2011)
2. Biological Barriers to Flavonoid Bioavailability, Ohio State University College of Pharmacy, Columbus, OH (2010)
3. Biological Barriers to Flavonoid Bioavailability, Beijing University College of Pharmacy, Beijing, China (2010)
4. Biopharmaceutical Basis of Dietary Supplement Standardization: Variable Isoflavone Contents of Red Clover Products Affect Their Intestinal Disposition. Stephen W.J.Wang, Ming Hu. United States Pharmacopeia Annual Meeting, Denver, CO. (2006)
Professional Societies:
American Society of Pharmacology and Experimental Therapeutics (elected 1996)
American Association of Pharmaceutical Scientists,American Chemical Society
歡迎廣大師生踴躍參加!